Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Baxter
Boehringer Ingelheim
Moodys
McKesson

Last Updated: May 27, 2022

Investigational Drug Information for Ceftobiprole


✉ Email this page to a colleague

« Back to Dashboard

What is the drug development status for Ceftobiprole?

Ceftobiprole is an investigational drug.

There have been 21 clinical trials for Ceftobiprole. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2004.

The most common disease conditions in clinical trials are Infections, Infection, and Communicable Diseases. The leading clinical trial sponsors are Basilea Pharmaceutica, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., and Department of Health and Human Services.

Recent Clinical Trials for Ceftobiprole
TitleSponsorPhase
Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation.Centre Hospitalier Lyon SudN/A
Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation.CHU de NîmesN/A
Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation.Hôpital Haut-LévêqueN/A

See all Ceftobiprole clinical trials

Clinical Trial Summary for Ceftobiprole

Top disease conditions for Ceftobiprole
Top clinical trial sponsors for Ceftobiprole

See all Ceftobiprole clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Baxter
Boehringer Ingelheim
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.